Literature DB >> 7471073

Chromosomal analysis of human prostatic adenocarcinoma cell lines.

Y Ohnuki, M M Marnell, M S Babcock, J F Lechner, M E Kaighn.   

Abstract

Although detailed cytogenetic analysis has been carried out in many types of cancer, there is little information on the chromosomal makeup of prostatic cancer cells. Karyological analyses of cell lines derived from both metastatic and primary prostatic carcinoma have been carried out by Q-, C-, and sequential banding techniques. The metastatic line, PC-3, isolated from a bone marrow specimen, is an established epithelial line which is tumorigenic in nude, athymic mice and forms colonies in semisolid agar suspension. A subline, PC-3/M, was isolated from a PC-3-induced mouse tumor. Karyotypic analysis of PC-3 by Q- and C-banding showed the cells to be aneuploid at all culture passage levels. The modal chromosome number shifted from 62 to 55 between the 5th and 50th passages. PC-3 has a unique karyotype. Chromosomes 2, 3, 5, 15, and Y were always absent. At least 11 different marker chromosomes were observed. The subline, PC-3/M, had a similar karyotype and retained the parental PC-3 markers. PC-3/M had a more restricted chromosomal frequency distribution range. Nearly 73% of the PC-3/M cells examined had 60 or 61 chromosomes in contrast to the wide distribution seen in PC-3. Silver staining for nucleolus organizer regions indicated that the number of functional nucleolus organizer regions in PC-3 was proportional to the number of acrocentric chromosomes. Banding analysis of PC-5-PI isolated from primary prostatic adenocarcinoma indicated that this line also had a characteristic karyotype with 28% pseudodiploid and 72% pseudotetraploid components. All metaphases examined were partially trisomic in chromosome 9 and lacked a demonstrable Y chromosome.

Entities:  

Mesh:

Year:  1980        PMID: 7471073

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Ruan Jin Zhao; Xueji Zhang; Lun Yang; Shu-Feng Zhou; Zong-Fu Mao
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

2.  In vivo pH imaging with (99m)Tc-pHLIP.

Authors:  Sven Macholl; Matthew S Morrison; Peter Iveson; Bente E Arbo; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman; Edvin Johannesen
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

3.  Cytotoxic effects of zoledronic acid-loaded hydroxyapatite and bone cement in malignant tumors.

Authors:  Kazutaka Koto; Hiroaki Murata; Yasushi Sawai; Eishi Ashihara; Motoyuki Horii; Toshikazu Kubo
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

4.  Selective growth of normal adult human urothelial cells in serum-free medium.

Authors:  D Kirk; S Kagawa; G Vener; K S Narayan; Y Ohnuki; L W Jones
Journal:  In Vitro Cell Dev Biol       Date:  1985-03

5.  Apoptotic and antioxidant effects in HCT-116 colorectal carcinoma cells by a spiro-acridine compound, AMTAC-06.

Authors:  Sâmia Sousa Duarte; Daiana Karla Frade Silva; Thaís Mangeon Honorato Lisboa; Rawny Galdino Gouveia; Camyla Caroliny Neves de Andrade; Valgrícia Matias de Sousa; Rafael Carlos Ferreira; Ricardo Olimpio de Moura; Joilly Nilce Santana Gomes; Patricia Mirella da Silva; Fátima de Lourdes Assunção Araújo de Azevedo; Tatjana S L Keesen; Juan Carlos Ramos Gonçalves; Leônia Maria Batista; Marianna Vieira Sobral
Journal:  Pharmacol Rep       Date:  2022-03-17       Impact factor: 3.024

6.  Analysis of gene amplification in human tumor cell lines.

Authors:  M Fukumoto; D H Shevrin; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.

Authors:  Kristine Glunde; Tariq Shah; Paul T Winnard; Venu Raman; Tomoyo Takagi; Farhad Vesuna; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

8.  SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines.

Authors:  So Young Choi; Ju Mi Jeon; Ann Yae Na; Oh Kwang Kwon; In Hyuk Bang; Yun-Sok Ha; Eun Ju Bae; Byung-Hyun Park; Eun Hye Lee; Tae Gyun Kwon; Jun Nyung Lee; Sangkyu Lee
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

9.  Genomic analyses of the metastasis-derived prostate cancer cell lines LNCaP, VCaP, and PC3-AR.

Authors:  Karolina Sienkiewicz; Chunsong Yang; Bryce M Paschal; Aakrosh Ratan
Journal:  Prostate       Date:  2021-12-24       Impact factor: 4.104

10.  Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.

Authors:  Takumi Shiraishi; James E Verdone; Jessie Huang; Ulf D Kahlert; James R Hernandez; Gonzalo Torga; Jelani C Zarif; Tamir Epstein; Robert Gatenby; Annemarie McCartney; Jennifer H Elisseeff; Steven M Mooney; Steven S An; Kenneth J Pienta
Journal:  Oncotarget       Date:  2015-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.